Management of High-Risk Neuroblastoma with Soft-Tissue-Only Disease in the Era of Anti-GD2 Immunotherapy.
Gorostegui M, Muñoz JP, Perez-Jaume S, Simao-Rafael M, Larrosa C, Garraus M, Salvador N, Lavarino C, Krauel L, Mañe S, Castañeda A, Mora J.
Gorostegui M, et al. Among authors: krauel l.
Cancers (Basel). 2024 Apr 29;16(9):1735. doi: 10.3390/cancers16091735.
Cancers (Basel). 2024.
PMID: 38730688
Free PMC article.